Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990073482> ?p ?o ?g. }
- W2990073482 endingPage "112390" @default.
- W2990073482 startingPage "112390" @default.
- W2990073482 abstract "Tougu Xiaotong capsules (TXC) are an herbal compound commonly used to treat osteoarthritis (OA) in China.We attempted to verify TXC's therapeutic effects and mechanisms related to the p38 mitogen-activated protein kinase (MAPK) pathway in vivo and in vitro.TXC's therapeutic effects were assessed by observing cartilage degeneration and inflammatory factors in a modified Hulth's model (in vivo) and a lipopolysaccharides (LPS)-exposed cellular model (in vitro). The expression of biomarkers related to p38 MAPK pathway-mediated inflammation was also investigated.TXC treatment reversed cartilage degeneration related biomarkers (ADAMTS 4, ADAMTS 5, Col I, Col V, MMP 3, MMP 9, and MMP 13) and inflammation factors (IL-1β, TNF-α, and IL-6) in both the animal and cellular OA models. Expression of p-p38 MAPK was downregulated following TXC administration, and changes to microRNAs in the cellular models were recovered. These results indicated that the p38 MAPK pathway-related mechanism may involve therapeutic effects of TXC.This study verified TXC's efficacy to treat OA in vivo and in vitro and suggests that p38 MAPK pathway-related mechanisms may be involved in TXC's therapeutic effects." @default.
- W2990073482 created "2019-12-05" @default.
- W2990073482 creator A5001787597 @default.
- W2990073482 creator A5006713209 @default.
- W2990073482 creator A5015850576 @default.
- W2990073482 creator A5023738242 @default.
- W2990073482 creator A5030710878 @default.
- W2990073482 creator A5047597076 @default.
- W2990073482 creator A5053807041 @default.
- W2990073482 creator A5055199690 @default.
- W2990073482 creator A5073895879 @default.
- W2990073482 creator A5078792754 @default.
- W2990073482 creator A5086580108 @default.
- W2990073482 creator A5090061270 @default.
- W2990073482 date "2020-03-01" @default.
- W2990073482 modified "2023-10-18" @default.
- W2990073482 title "Tougu Xiaotong capsules may inhibit p38 MAPK pathway-mediated inflammation: In vivo and in vitro verification" @default.
- W2990073482 cites W1536352134 @default.
- W2990073482 cites W1696260634 @default.
- W2990073482 cites W1754220768 @default.
- W2990073482 cites W1878270707 @default.
- W2990073482 cites W1979092379 @default.
- W2990073482 cites W1985608961 @default.
- W2990073482 cites W1990732405 @default.
- W2990073482 cites W1991260058 @default.
- W2990073482 cites W2019223535 @default.
- W2990073482 cites W2020380331 @default.
- W2990073482 cites W2025707119 @default.
- W2990073482 cites W2050178836 @default.
- W2990073482 cites W2054486269 @default.
- W2990073482 cites W2060820431 @default.
- W2990073482 cites W2062106607 @default.
- W2990073482 cites W2089605568 @default.
- W2990073482 cites W2096000712 @default.
- W2990073482 cites W2124032632 @default.
- W2990073482 cites W2134668680 @default.
- W2990073482 cites W2143186554 @default.
- W2990073482 cites W2204993185 @default.
- W2990073482 cites W2481064200 @default.
- W2990073482 cites W2551137278 @default.
- W2990073482 cites W2557917628 @default.
- W2990073482 cites W2697128618 @default.
- W2990073482 cites W2733298080 @default.
- W2990073482 cites W2735521919 @default.
- W2990073482 cites W2737257991 @default.
- W2990073482 cites W2772379709 @default.
- W2990073482 cites W2773697700 @default.
- W2990073482 cites W2786557670 @default.
- W2990073482 cites W2797869734 @default.
- W2990073482 cites W2884288842 @default.
- W2990073482 cites W2886676918 @default.
- W2990073482 cites W2892378839 @default.
- W2990073482 cites W2893327675 @default.
- W2990073482 cites W2895897067 @default.
- W2990073482 doi "https://doi.org/10.1016/j.jep.2019.112390" @default.
- W2990073482 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31760158" @default.
- W2990073482 hasPublicationYear "2020" @default.
- W2990073482 type Work @default.
- W2990073482 sameAs 2990073482 @default.
- W2990073482 citedByCount "9" @default.
- W2990073482 countsByYear W29900734822020 @default.
- W2990073482 countsByYear W29900734822021 @default.
- W2990073482 countsByYear W29900734822022 @default.
- W2990073482 countsByYear W29900734822023 @default.
- W2990073482 crossrefType "journal-article" @default.
- W2990073482 hasAuthorship W2990073482A5001787597 @default.
- W2990073482 hasAuthorship W2990073482A5006713209 @default.
- W2990073482 hasAuthorship W2990073482A5015850576 @default.
- W2990073482 hasAuthorship W2990073482A5023738242 @default.
- W2990073482 hasAuthorship W2990073482A5030710878 @default.
- W2990073482 hasAuthorship W2990073482A5047597076 @default.
- W2990073482 hasAuthorship W2990073482A5053807041 @default.
- W2990073482 hasAuthorship W2990073482A5055199690 @default.
- W2990073482 hasAuthorship W2990073482A5073895879 @default.
- W2990073482 hasAuthorship W2990073482A5078792754 @default.
- W2990073482 hasAuthorship W2990073482A5086580108 @default.
- W2990073482 hasAuthorship W2990073482A5090061270 @default.
- W2990073482 hasConcept C109523444 @default.
- W2990073482 hasConcept C126322002 @default.
- W2990073482 hasConcept C150903083 @default.
- W2990073482 hasConcept C167814343 @default.
- W2990073482 hasConcept C184235292 @default.
- W2990073482 hasConcept C202751555 @default.
- W2990073482 hasConcept C203014093 @default.
- W2990073482 hasConcept C207001950 @default.
- W2990073482 hasConcept C2776224515 @default.
- W2990073482 hasConcept C2776914184 @default.
- W2990073482 hasConcept C502942594 @default.
- W2990073482 hasConcept C51551487 @default.
- W2990073482 hasConcept C55493867 @default.
- W2990073482 hasConcept C55728118 @default.
- W2990073482 hasConcept C57074206 @default.
- W2990073482 hasConcept C71924100 @default.
- W2990073482 hasConcept C86803240 @default.
- W2990073482 hasConcept C95444343 @default.
- W2990073482 hasConcept C98274493 @default.
- W2990073482 hasConceptScore W2990073482C109523444 @default.
- W2990073482 hasConceptScore W2990073482C126322002 @default.